| Value | Category | Cases | |
|---|---|---|---|
| 1 | Oral PrEP only | 793 |
60.8%
|
| 2 | 2 monthly Injectable (im) cabotegravir only | 507 |
38.9%
|
| 3 | DapiRing Only | 0 |
0%
|
| 4 | 6 monthly subcutaneous lenocapovir | 0 |
0%
|
| 5 | Oral PrEP and Injectable cabotegravir | 4 |
0.3%
|
| 96 | Other | 0 |
0%
|
| Sysmiss | 226 |